title: Impact of adverse events on ventricular assist device outcomes.
abstract: Left ventricular assist devices have been proven to be superior to medical therapy for advanced heart failure patients awaiting heart transplantation and viable alternatives to transplantation for destination therapy patients. Improvements in the design of ventricular assist devices have been rewarded by a decrease in adverse events and an increase in survival. Despite significant progress, even the latest generation left ventricular assist devices are burdened by a significant long-term adverse events profile that will increasingly challenge physicians as patients survive longer on implantable mechanical circulatory support. In this review, we analyze the impact of long-term adverse events on clinical outcomes in the major trials of continuous flow left ventricular assist devices. We discuss several of the more pertinent and interesting adverse events, examine their potential causes, and explore their future implications.
authors: Division of Cardiology, Montefiore Medical Center, 3400 Bainbridge Avenue, Bronx, NY 10467, USA.
authors: Aleksandar
authors: A
authors: Adzic
authors: Snehal R
authors: SR
authors: Patel
authors: Simon
authors: S
authors: Maybaum
mesh_terms: D001022:Aortic Valve Insufficiency / Q000209:etiology; D004868:Equipment Failure; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D016459:Prosthesis-Related Infections / Q000209:etiology; D020521:Stroke / Q000209:etiology; D013927:Thrombosis / Q000209:etiology